Brief: ProQR Therapeutics Q1 EPS EUR -0.13
May 12 (Reuters) - ProQR Therapeutics Q1 revenue EUR 2.033 million vs. IBES estimate EUR 5.25 million. Q1 basic EPS EUR -0.13 Q1 operating income EUR -13.649 million Q1 net income EUR -13.383 million
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview